Abstract
Polymeric micelles (PMs) belong to supramolecular core-shell-type assemblies. PMs are from amphiphilic block copolymers with several tens of nanometers in diameter. An important criterion verifying the effectiveness of micellar drug carriers is the ability to control the location and time over which drug release occurs. The pH variations in the body are particularly important in the development of micellar carriers for treating diseases such as cancer and inflammation. pH-sensitive PMs have emerged as a fascinating class of nanoscopic drug carriers that can be elegantly applied for programmed drug and gene delivery. In this review, we provide an analysis of recent literature reports on these pH-sensitive PMs. Different approaches that have been taken to develop pH-sensitive PMs are highlighted, including incorporating pH-sensitive building blocks such as poly(L-histidine) and poly(β-amino ester), and acid degradable linkages such as hydrazones and acetals. The potential applications of pH-sensitive PMs within the biomedical field are also summarized.
Keywords: pH-Sensitive polymeric micelles, programmable drug and gene delivery, pH-sensitive building blocks, acid degradable linkages, biomedical applications, copolymers, drug release, nanoscopic drug carriers, hydrazones, acetals
Current Pharmaceutical Design
Title:pH-Sensitive Polymeric Micelles for Programmable Drug and Gene Delivery
Volume: 18 Issue: 23
Author(s): Zhihong Liu and Na Zhang
Affiliation:
Keywords: pH-Sensitive polymeric micelles, programmable drug and gene delivery, pH-sensitive building blocks, acid degradable linkages, biomedical applications, copolymers, drug release, nanoscopic drug carriers, hydrazones, acetals
Abstract: Polymeric micelles (PMs) belong to supramolecular core-shell-type assemblies. PMs are from amphiphilic block copolymers with several tens of nanometers in diameter. An important criterion verifying the effectiveness of micellar drug carriers is the ability to control the location and time over which drug release occurs. The pH variations in the body are particularly important in the development of micellar carriers for treating diseases such as cancer and inflammation. pH-sensitive PMs have emerged as a fascinating class of nanoscopic drug carriers that can be elegantly applied for programmed drug and gene delivery. In this review, we provide an analysis of recent literature reports on these pH-sensitive PMs. Different approaches that have been taken to develop pH-sensitive PMs are highlighted, including incorporating pH-sensitive building blocks such as poly(L-histidine) and poly(β-amino ester), and acid degradable linkages such as hydrazones and acetals. The potential applications of pH-sensitive PMs within the biomedical field are also summarized.
Export Options
About this article
Cite this article as:
Liu Zhihong and Zhang Na, pH-Sensitive Polymeric Micelles for Programmable Drug and Gene Delivery, Current Pharmaceutical Design 2012; 18 (23) . https://dx.doi.org/10.2174/138161212801227122
DOI https://dx.doi.org/10.2174/138161212801227122 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Interaction of Probenecid with the Breast Cancer Resistance Protein Transporter (BCRP/ABCG2)
Letters in Drug Design & Discovery Renal Cell Cancer and Positron Emission Tomography- an Evolving Diagnostic and Therapeutic Relationship
Current Medical Imaging Nanocarriers Based Anticancer Drugs: Current Scenario and Future Perceptions
Current Drug Targets Acute and Long-Term Effects of Cannabis Use: A Review
Current Pharmaceutical Design Carbonic Anhydrase Based Biomarkers: Potential Application in Human Health and Environmental Sciences
Current Biomarkers (Discontinued) Recent Patents on the Synthesis and Application of Silica Nanoparticles for Drug Delivery
Recent Patents on Biotechnology The Production and Role of Gastrin-17 and Gastrin-17-Gly in Gastrointestinal Cancers
Protein & Peptide Letters Dynamic Contrast Enhanced Magnetic Resonance Imaging in Oncology:Theory, Data Acquisition,Analysis, and Examples
Current Medical Imaging Sequential Therapy For Helicobacter pylori in Elderly Patients: Effectiveness, Safety and Predictors of Success
Letters in Drug Design & Discovery Purification and Biological Evaluation of Some Bioactive Metabolomics as Antimicrobial Agent
Letters in Drug Design & Discovery Therapeutic Challenges in Neuroendocrine Tumors
Anti-Cancer Agents in Medicinal Chemistry Hedgehog Signaling in the Normal and Neoplastic Mammary Gland
Current Drug Targets Phosphodiesterase Inhibitors as a Target for Cognition Enhancement in Aging and Alzheimer’s Disease: A Translational Overview
Current Pharmaceutical Design Gastric Ulcer Complicating a Selective Internal Radiation Therapy (SIRT) Procedure for Colorectal Carcinoma Metastasized to the Liver
Current Radiopharmaceuticals Is Src a Viable Target for Treating Solid Tumours?
Current Cancer Drug Targets Can Targeting the Incretin Pathway Dampen RAGE-Mediated Events in Diabetic Nephropathy?
Current Drug Targets Prophylactic Vaccine Approach for Colon and Pancreatic Cancers: Present and Future
Current Medicinal Chemistry Organoids: Current Implications and Pharmaceutical Applications in Liver Diseases
Current Molecular Pharmacology Mechanisms of Resistance to Chemotherapy in Gastric Cancer
Anti-Cancer Agents in Medicinal Chemistry Counter-Regulatory Role of Bile Acid Activated Receptors in Immunity and Inflammation
Current Molecular Medicine